Zydus Wellness Limited (BOM:531335)
India · Delayed Price · Currency is INR 414.55
-1.50 (-0.36%)
At close: Feb 11, 2026
Zydus Wellness Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 33,922 | 27,089 | 23,278 | 22,548 | 20,091 | 18,667 |
Other Revenue | -28 | - | - | - | - | - |
| 33,894 | 27,089 | 23,278 | 22,548 | 20,091 | 18,667 | |
Revenue Growth (YoY) | 31.45% | 16.37% | 3.24% | 12.23% | 7.63% | 5.65% |
Cost of Revenue | 14,589 | 12,781 | 11,384 | 11,593 | 9,926 | 8,588 |
Gross Profit | 19,305 | 14,308 | 11,894 | 10,955 | 10,165 | 10,079 |
Selling, General & Admin | 5,280 | 3,250 | 2,613 | 4,991 | 4,626 | 4,270 |
Other Operating Expenses | 9,746 | 7,256 | 6,197 | 2,589 | 2,055 | 2,366 |
Operating Expenses | 16,080 | 10,798 | 9,051 | 7,830 | 6,944 | 6,887 |
Operating Income | 3,225 | 3,510 | 2,843 | 3,125 | 3,220 | 3,192 |
Interest Expense | -632 | -116 | -237 | -158 | -251.1 | -834 |
Interest & Investment Income | 31 | 31 | 110 | 32 | 92.9 | 67.6 |
Currency Exchange Gain (Loss) | 21 | -1 | 1 | -2 | -8.8 | - |
Other Non Operating Income (Expenses) | -73 | 3 | 1 | -2 | -4 | -4 |
EBT Excluding Unusual Items | 2,572 | 3,427 | 2,718 | 2,995 | 3,049 | 2,422 |
Gain (Loss) on Sale of Investments | 99 | 99 | 25 | 16 | 11.1 | 21.8 |
Gain (Loss) on Sale of Assets | 3 | 3 | - | -1 | -0.3 | - |
Other Unusual Items | -66 | 59 | -142 | -101 | - | -1,321 |
Pretax Income | 2,266 | 3,588 | 2,601 | 2,909 | 3,060 | 1,122 |
Income Tax Expense | 195 | 119 | -68 | -195 | -28.5 | -65.2 |
Earnings From Continuing Operations | 2,071 | 3,469 | 2,669 | 3,104 | 3,089 | 1,187 |
Net Income | 2,071 | 3,469 | 2,669 | 3,104 | 3,089 | 1,187 |
Net Income to Common | 2,071 | 3,469 | 2,669 | 3,104 | 3,089 | 1,187 |
Net Income Growth | -36.34% | 29.97% | -14.01% | 0.50% | 160.15% | -16.22% |
Shares Outstanding (Basic) | 317 | 318 | 318 | 318 | 318 | 304 |
Shares Outstanding (Diluted) | 317 | 318 | 318 | 318 | 318 | 304 |
Shares Change (YoY) | -0.24% | - | - | - | 4.76% | 5.34% |
EPS (Basic) | 6.53 | 10.90 | 8.39 | 9.76 | 9.71 | 3.91 |
EPS (Diluted) | 6.53 | 10.90 | 8.39 | 9.76 | 9.71 | 3.91 |
EPS Growth | -36.18% | 29.97% | -14.01% | 0.50% | 148.33% | -20.47% |
Free Cash Flow | - | 3,137 | 2,179 | 467 | 1,614 | 2,671 |
Free Cash Flow Per Share | - | 9.86 | 6.85 | 1.47 | 5.07 | 8.79 |
Dividend Per Share | - | 1.200 | 1.000 | 1.000 | 1.000 | 1.000 |
Dividend Growth | - | 20.00% | - | - | - | - |
Gross Margin | 56.96% | 52.82% | 51.09% | 48.59% | 50.59% | 54.00% |
Operating Margin | 9.52% | 12.96% | 12.21% | 13.86% | 16.03% | 17.10% |
Profit Margin | 6.11% | 12.81% | 11.47% | 13.77% | 15.37% | 6.36% |
Free Cash Flow Margin | - | 11.58% | 9.36% | 2.07% | 8.03% | 14.31% |
EBITDA | 3,551 | 3,784 | 3,048 | 3,333 | 3,403 | 3,405 |
EBITDA Margin | 10.48% | 13.97% | 13.09% | 14.78% | 16.94% | 18.24% |
D&A For EBITDA | 325.75 | 274 | 205 | 208 | 182.2 | 213.2 |
EBIT | 3,225 | 3,510 | 2,843 | 3,125 | 3,220 | 3,192 |
EBIT Margin | 9.52% | 12.96% | 12.21% | 13.86% | 16.03% | 17.10% |
Effective Tax Rate | 8.61% | 3.32% | - | - | - | - |
Revenue as Reported | 33,954 | 27,225 | 23,417 | 22,597 | 20,195 | 18,756 |
Advertising Expenses | - | - | - | 2,587 | 2,348 | 2,296 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.